1. Home
  2. FMS vs SCLXW Comparison

FMS vs SCLXW Comparison

Compare FMS & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMS
  • SCLXW
  • Stock Information
  • Founded
  • FMS 1996
  • SCLXW N/A
  • Country
  • FMS Germany
  • SCLXW United States
  • Employees
  • FMS 111513
  • SCLXW 115
  • Industry
  • FMS Misc Health and Biotechnology Services
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • Sector
  • FMS Health Care
  • SCLXW Health Care
  • Exchange
  • FMS Nasdaq
  • SCLXW Nasdaq
  • Market Cap
  • FMS 13.8B
  • SCLXW N/A
  • IPO Year
  • FMS 1996
  • SCLXW N/A
  • Fundamental
  • Price
  • FMS $24.46
  • SCLXW $0.09
  • Analyst Decision
  • FMS Hold
  • SCLXW
  • Analyst Count
  • FMS 1
  • SCLXW 0
  • Target Price
  • FMS $25.00
  • SCLXW N/A
  • AVG Volume (30 Days)
  • FMS 428.6K
  • SCLXW 4.0K
  • Earning Date
  • FMS 05-06-2025
  • SCLXW 03-07-2025
  • Dividend Yield
  • FMS 2.59%
  • SCLXW N/A
  • EPS Growth
  • FMS 7.65
  • SCLXW N/A
  • EPS
  • FMS 1.89
  • SCLXW N/A
  • Revenue
  • FMS $20,018,541,263.00
  • SCLXW $55,152,000.00
  • Revenue This Year
  • FMS $5.05
  • SCLXW N/A
  • Revenue Next Year
  • FMS $3.90
  • SCLXW N/A
  • P/E Ratio
  • FMS $25.68
  • SCLXW N/A
  • Revenue Growth
  • FMS N/A
  • SCLXW 22.02
  • 52 Week Low
  • FMS $17.93
  • SCLXW $0.18
  • 52 Week High
  • FMS $25.96
  • SCLXW $0.18
  • Technical
  • Relative Strength Index (RSI)
  • FMS 52.98
  • SCLXW N/A
  • Support Level
  • FMS $23.52
  • SCLXW N/A
  • Resistance Level
  • FMS $24.32
  • SCLXW N/A
  • Average True Range (ATR)
  • FMS 0.60
  • SCLXW 0.00
  • MACD
  • FMS -0.00
  • SCLXW 0.00
  • Stochastic Oscillator
  • FMS 76.51
  • SCLXW 0.00

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: